Pharsight

INCYTE patents facing oppositions

Top patents of INCYTE facing oppositions at the European Patent Office (EPO).

Patent Number Grant Date Patent Title Expected Expiration Date Facing Oppositions Activity Alert
EP2919766B1 26 May, 2021 Sustained-release dosage forms of ruxolitinib Nov, 2033 4
EP2300455B1 Salts of 2-fluoro-n-methyl-4-[7-(quinolin-6-yl-methyl) - imidazo [1, 2-b] [1, 2, 4] triazin-2-yl] benzamide and processes related to preparing the same NA 1
EP2671882B1 Pyrrolo[2,3-b]pyridin-4-yl-amines and pyrrolo[2m3-b]pyrimidin-4-yl-amines as janus kinase inhibitors NA 1
EP3070090B1 12 Dec, 2018 Use of salts of the janus kinase inhibitor (r)-3-(4-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-1h- pyrazol-1-yl)-3- cyclopentylpropanenitrile Jun, 2028 1
EP3184526B1 03 Oct, 2018 Pyrrolo[2,3-d]pyrimidine derivatives as janus kinase inhibitor NA 1
EP3050882B1 31 Jan, 2018 Piperidin-4-yl azetidine derivatives as jak1 inhibitors Mar, 2031 1